KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Assets (2018 - 2026)

Aquestive Therapeutics has reported Return on Assets over the past 8 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Assets for Q4 2025 was 0.01% at Aquestive Therapeutics, up from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q4 2023 and troughed at 0.01% in Q3 2022.
  • A 5-year average of 0.01% and a median of 0.01% in 2023 define the central range for Return on Assets.
  • Biggest five-year swings in Return on Assets: changed 0bps in 2021 and later grew 1bps in 2023.
  • Year by year, Return on Assets stood at 0.01% in 2021, then increased by 10bps to 0.01% in 2022, then skyrocketed by 87bps to 0.0% in 2023, then plummeted by -210bps to 0.0% in 2024, then decreased by -24bps to 0.01% in 2025.
  • Business Quant data shows Return on Assets for AQST at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.